No Sweat: Miramar Labs Snags $10M in Series D Financing
February 14, 2014
Medical device company Miramar Labs has raised $10 million in Series D funding from Aisling Capital, Cross Creek Capital, Domain Associates, Morgenthaler Ventures and RusnanoMedInvest. The company's miraDry System is designed to treat excessive underarm sweat, delivering energy non-invasively to the area under the arm where the sweat glands reside and creating localized heat to destroy and eliminate the glands. Miramar will use the new funds to expand sales activities around the world, support commercialization efforts in Europe and support R&D efforts on products for new indications. Miramar has raised about $71 million over four rounds since 2006, previously receiving a $74 million valuation with a $36 million Series C round in 2011.